Expert Analysis

Hepatitis and Opportunistic Diseases

Source: CCO Independent Conference Coverage of the 2007 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Hepatitis and Opportunistic Diseases

Faculty:

Richard E. Chaisson, MD
Bruce Polsky, MD
Jürgen K. Rockstroh, MD

CME CREDIT INFORMATION

Release Date: 05/09/07

Expiration Date: 05/08/08

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.6 Nursing CE credits

Pharmacists: 1.4 contact hours (0.14 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Recall recent data regarding the incidence of opportunistic infections and their relative impact on mortality and morbidity
Summarize the impact of hepatitis C virus coinfection in HIV-infected patients on treatment outcomes
Explain updates on hepatitis B virus vaccination and treatment in the setting of HIV coinfection

Topics covered include:

HIV and Opportunistic Disease Related Morbidity and Mortality
Mortality in a Tuberculosis Endemic, Resource-Limited Settings
Improvements in Tuberculosis Testing
Sexual Transmission of Hepatitis C Virus in Men Who Have Sex With Men
Noninvasive Tests for Liver Fibrosis and HCV Treatment
Treatment Outcomes in HCV/HIV-Coinfected Patients
Improving Response to Hepatitis B Vaccination in HIV-Positive Individuals
Entecavir and Potential for Selection of M184V Mutation in HBV/HIV-coinfected Patients

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.